Myriad Genetics (MYGN) Return on Capital Employed (2011 - 2026)
Myriad Genetics (MYGN) reported Return on Capital Employed of 69.45% for Q1 2026, down 5507.0% year-over-year from 1.28% in Q1 2025, and down 4.67% quarter-over-quarter from 66.35% in Q4 2025.
Myriad Genetics (MYGN) Return on Capital Employed (2011 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has 16 years of Return on Capital Employed data on file, last reported at 69.45% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 69.45%, down 5507.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 69.45% (down 5507.0% YoY), and the FY2025 annual result was 52.8%, down 3942.0% from the prior year.
- Return on Capital Employed fell to 69.45% in Q1 2026 per MYGN's latest filing, from 66.35% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 12.15% in Q3 2022 and troughed at 75.81% in Q3 2025.
- A 5-year average of 30.08% and a median of 16.43% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed soared 1655 bps in 2024, then sank 6334 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 13.16% in 2022, then sank by 97 bps to 25.95% in 2023, then jumped by 47 bps to 13.86% in 2024, then slumped by 379 bps to 66.35% in 2025, then slipped by 5 bps to 69.45% in 2026.
- Business Quant data shows MYGN's Return on Capital Employed at 69.45% in Q1 2026, 66.35% in Q4 2025, and 75.81% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 67.98% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 14.57% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 10.24% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -3.63% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 45.73% |
| 10 | Myriad Genetics | 411.34 Mn | 286.94 Mn | 137.60 Mn | -69.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.45% |
| Dec 31, 2025 | -66.35% |
| Sep 30, 2025 | -75.81% |
| Jun 30, 2025 | -65.00% |
| Mar 31, 2025 | -14.38% |
| Dec 31, 2024 | -13.86% |
| Sep 30, 2024 | -12.47% |
| Jun 30, 2024 | -16.43% |
| Mar 31, 2024 | -23.73% |
| Dec 31, 2023 | -25.95% |
| Sep 30, 2023 | -29.01% |
| Jun 30, 2023 | -27.49% |
| Mar 31, 2023 | -16.07% |
| Dec 31, 2022 | -13.16% |
| Sep 30, 2022 | -12.15% |
| Jun 30, 2022 | -14.95% |
| Mar 31, 2022 | -15.10% |
| Dec 31, 2021 | -16.95% |
| Sep 30, 2021 | -20.54% |
| Jun 30, 2021 | -18.09% |